WORCESTER, Mass.--(BUSINESS WIRE)--May 4, 2006--Biovest International, Inc. (OTCBB: BVTI.OB - News), a biopharmaceutical company focused on the development of patient specific immunotherapeutics and automated cell culture instrumentation, has appointed Dr. James Zabrecky as Vice President for Biologics Development of its Biovax subsidiary.
